US Broker Ratings

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Exploring a 34.56% Potential Upside with Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing attention in the biotechnology sector with its focus on rare neuroendocrine diseases. As a commercial-stage biopharmaceutical company headquartered in Boston, Massachusetts, Rhythm Pharmaceuticals..

Soleno Therapeutics (SLNO) Stock Analysis: Unpacking the 38.78% Potential Upside

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is capturing investor attention with a compelling 38.78% potential upside, reflecting a robust consensus among analysts. As a clinical-stage biopharmaceutical company, Soleno is primarily focused..

BeOne Medicines Ltd. (ONC) Stock Analysis: A 34% Upside in the Biotech Revolution

For investors searching for promising opportunities in the biotechnology sector, BeOne Medicines Ltd. (ONC) stands out with a potential upside of 34.36% according to analyst ratings. Based in Basel, Switzerland,..

RadNet, Inc. (RDNT) Investor Outlook: Strong Buy Ratings and 29.59% Upside Potential

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, operates within the diagnostics and research industry, offering a diverse range of outpatient diagnostic imaging services. The company boasts..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Biotech Leader with 41% Upside Potential

BridgeBio Pharma, Inc. (BBIO) is making waves in the biotechnology sector with its innovative approach to treating genetic diseases and cancer. Headquartered in Palo Alto, California, the company has positioned..

BrightSpring Health Services (BTSG) Stock Analysis: A 22.57% Potential Upside in Healthcare Innovation

BrightSpring Health Services, Inc. (BTSG) is gaining attention in the healthcare sector with its robust service offerings and a promising potential upside of 22.57%. As a significant player in the..

Oscar Health, Inc. (OSCR) Stock Analysis: Assessing a 42.2% Revenue Growth in the Healthcare Plans Industry

Oscar Health, Inc. (NYSE: OSCR), a healthcare technology company, has been making waves in the healthcare plans industry with its innovative offerings and impressive revenue growth. Headquartered in New York,..

Bruker Corporation (BRKR): Investor Outlook on a 47% Potential Upside and Robust Revenue Growth

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, is making waves in the medical devices industry with its promising growth trajectory. Headquartered in Billerica, Massachusetts, Bruker specializes..

Alcon Inc. (ALC) Stock Analysis: Healthcare Giant Sees 23.88% Potential Upside

Alcon Inc. (NYSE: ALC), a prominent player in the global eye care industry, is drawing considerable attention from investors as it continues to exhibit steady growth in a challenging healthcare..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A 20% Revenue Growth Star in the Medical Devices Sector

In the fast-evolving landscape of healthcare technology, iRhythm Technologies, Inc. (NASDAQ: IRTC) stands out as a leader in digital healthcare solutions, with its innovative approach to cardiac monitoring. This San..

Genmab A/S (GMAB) Stock Analysis: Exploring a 40.3% Potential Upside in Biotechnology

For investors seeking opportunities in the biotechnology sector, Genmab A/S (NASDAQ: GMAB) stands out with a compelling potential upside of 40.3%, as suggested by its average target price of $29.69..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating a 15.59% Potential Upside in the Healthcare Sector

Fresenius Medical Care AG (FMS), a stalwart in the healthcare sector, remains a significant player in the medical care facilities industry, providing crucial dialysis and related services globally. Headquartered in..

Amgen Inc. (AMGN) Stock Analysis: Exploring a Potential 8.77% Upside

Amgen Inc. (NASDAQ: AMGN), a stalwart in the healthcare sector, continues to capture investor attention with its robust pipeline of therapeutics and impressive financial metrics. As a key player in..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Gem with 14.38% Upside Potential

TG Therapeutics, Inc. (TGTX), a biopharmaceutical company headquartered in Morrisville, North Carolina, is making waves in the biotech sector. With a current market capitalization of $5.72 billion, TG Therapeutics is..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A Deep Dive into Its 54.12% Potential Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a pioneering entity in the biotechnology sector, is capturing the interest of investors thanks to its robust pipeline and strategic partnerships. With a current market..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a Potential 49.93% Upside with Strong Buy Ratings

Nuvalent, Inc. (NASDAQ: NUVL), a rising star in the biotechnology sector, is capturing investor attention with its promising pipeline and significant potential upside. Headquartered in Cambridge, Massachusetts, this clinical-stage biopharmaceutical..

Veeva Systems Inc. (VEEV) Stock Analysis: Navigating Growth in Healthcare Cloud Solutions

Veeva Systems Inc. (NYSE: VEEV) stands at the forefront of a transformative shift in the healthcare industry with its innovative cloud-based software solutions tailored for life sciences. Headquartered in Pleasanton,..

Elevance Health, Inc. (ELV) Stock Analysis: A 33.71% Potential Upside in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), a key player in the healthcare plans industry, stands as a compelling option for investors seeking opportunities in the healthcare sector. With a substantial market..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 26% Upside Potential

Integer Holdings Corporation (NYSE: ITGR), a notable player in the healthcare sector, specializes in medical devices with a robust market presence both domestically in the United States and internationally. With..

Insulet Corporation (PODD) Stock Analysis: A Healthcare Giant with 10.84% Upside Potential

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector, specializes in innovative medical devices designed to improve the quality of life for individuals with insulin-dependent diabetes. Headquartered in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds